Phase II trial of carboplatin and etoposide in metastatic breast cancer
- 15 February 1993
- Vol. 71 (4) , 1254-1257
- https://doi.org/10.1002/1097-0142(19930215)71:4<1254::aid-cncr2820710414>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Carboplatin activity in untreated metastatic breast cancer patients — results of a phase II studyCancer Chemotherapy and Pharmacology, 1991
- Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research.Journal of Clinical Oncology, 1991
- A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide.Journal of Clinical Oncology, 1989
- High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.Journal of Clinical Oncology, 1988
- Cisplatin in the treatment of metastatic breast carcinoma A prospective randomized trial of two dosage schedulesAmerican Journal of Clinical Oncology, 1982